| Test Name: |
HIV-1 PHENOSENSE GT (MONOGRAM PHENOTYPE/GENOTYPE) |
| Test Code: |
2192288 |
| Alias: |
551690
LAB12231
|
| CPT Code(s): |
87900
87901
87903
87904 x12
|
| Preferred Specimen: |
3 mL plasma |
| Container: |
2-EDTA (lavender) |
| Alternate Container: |
2-PPT (white) |
| Collection Instructions: |
Collect specimen in two lavender-top (EDTA) tubes or two PPT™ tubes. Do not use green-top (heparin) tubes. Centrifuge specimen within six hours of collection. Transfer plasma to one or more polypropylene screw-capped tube(s) (not "pop-top" or "snap-cap"), and freeze. Ship specimen frozen. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested. |
| Transport Temperature: |
Frozen |
| Rejection Criteria: |
PPT not centrifuged
quantity not sufficient for analysis
heparinized plasma
non frozen specimen |
| Limitations: |
This procedure should be used for patients with documented HIV-1 infection and viral loads ≥500 copies/mL. |
| Additional Information: |
PhenoSense® and PhenoSense GT® are trademarks of Monogram Biosciences®. |
| Schedule: |
TATL Report available in 16-22 days from receipt of specimen at LabCorp |
| Method: |
Phenotype: polymerase chain reaction (PCR) amplification and viral culture
Genotype: polymerase chain reaction (PCR) and DNA sequencing. |
| Performing Lab: |
LabCorp: #551690 |
| Clinical Significance: |
Determines viral phenotype and genotype resistance to three classes of commonly prescribed antiretroviral drugs: nucleoside reverse transcriptase inhibitors (NRTI), nonnucleoside reverse transcriptase inhibitors (NNRTI), and protease inhibitors (PI). Viral replication capacity is also included. |
| Use: |
Updated: 02/20/2026 |
|
The CPT codes included in this publication are in accordance with Current Procedural Terminology, a publication of the American Medical Association. CPT codes are provided here for the convenience of our clients; however, correct coding often varies from one carrier to another, and HealthLab may bill specific carriers using codes other than those shown. Clients who bill for services should verify the code(s) with the applicable payor to confirm that their use is appropriate in each case.
|
| Test Type: |
|